Funding Briefs

The nation’s second-largest foundation is doing some in-house spring cleaning—the second time in as many years. Philadelphia-based Pew Charitable Trusts, a collective of seven funds established by Sun Oil Co. founder Joseph N. Pew and family, has decided to streamline its recently installed management hierarchy by replacing it with a “flat” structure, eliminating four vice presidential slots and installing. individual program directors to manage each of the trusts six pr

| 3 min read

Register for free to listen to this article
Listen with Speechify
0:00
3:00
Share

The nation’s second-largest foundation is doing some in-house spring cleaning—the second time in as many years. Philadelphia-based Pew Charitable Trusts, a collective of seven funds established by Sun Oil Co. founder Joseph N. Pew and family, has decided to streamline its recently installed management hierarchy by replacing it with a “flat” structure, eliminating four vice presidential slots and installing. individual program directors to manage each of the trusts six program areas, chief among which is its Health and Human Services department. This department, which oversees the Pew Scholars program and provides funds for research and.training in the biomedical sciences, doles out between 30% and 40% of the trust’s grant money annually.

“The grantmaking policies remain the same,” says Tim Murray, acting director of Health Sciences and Human Services. “It Is business as usual for the application review process. This is strictly a structural reorganization.” Murray says that a permanent director ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies